サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医薬品ドラッグデリバリーの世界市場規模の調査・予測、用途別、投与経路別、地域別分析、2022-2029年
市場調査レポート
商品コード
1269690

医薬品ドラッグデリバリーの世界市場規模の調査・予測、用途別、投与経路別、地域別分析、2022-2029年

Global Pharmaceutical Drug Delivery Market Size study & Forecast, by Route Of Administration by Application and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品ドラッグデリバリーの世界市場規模の調査・予測、用途別、投与経路別、地域別分析、2022-2029年
出版日: 2023年05月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品ドラッグデリバリーの世界市場は、2021年に約1兆3,772億8,000万米ドルと評価され、予測期間2022-2029年には4.7%以上の堅調な成長率で成長すると予測されています。

医薬品ドラッグデリバリーは、医薬品を体内に投与するために使用される製剤または装置です。この技術は、化学的または生理学的なトリガーのいずれかを使用して治療の投与を制御できる媒体を使用して、身体の標的部位に医薬品を送達することによって機能します。医薬品の投与には、経口投与、静脈注射、皮膚吸収、吸入などのさまざまな経路があります。世界市場の成長は、人口に占める慢性疾患の割合の高さ、バイオシミラーや生物製剤の需要の急増、ドラッグデリバリー分野の研究に対する政府支援の増加、ヘルスケアに対する懸念や意識の高まりなどの要因によってもたらされています。世界保健機関（WHO）は、心血管疾患が死亡原因の第一位を占め、世界で約1,790万人の患者がいると発表しました。また、国際糖尿病連合によると、糖尿病人口は2045年までに7億8,300万人に達すると予想されています。

また、医薬品の研究開発への投資拡大が、世界の市場成長の触媒として作用しています。ヘルスケアの世界化により、医薬品の領域が拡大し、大きな成長機会となっています。製薬会社は、顧客の特定のニーズに合わせた医薬品を開発するために、研究開発に投資しています。Statistaによると、2020年、医薬品分野の研究開発費全体は2,070億米ドルを占め、2025年には約2,650億米ドルに達することが予測されています。これにより、医薬品の研究開発への投資の増加が市場開拓の要因となっています。さらに、自己投与や在宅医療の動向、技術進歩や新製品発売の増加が、予測期間中にさまざまな有利な機会をもたらしています。しかし、医薬品リコールや医薬品の不具合の増加は、2022-2029年の予測期間を通じて、市場の成長に課題しています。

医薬品ドラッグデリバリーの世界市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、その他の地域です。北米は、医薬品ドラッグデリバリーシステムが容易に入手可能であること、政府による支援が増加していること、政府の取り組みが増加していること、ヘルスケアインフラの近代化などにより、売上高で市場を独占しています。一方、アジア太平洋地域は、がん、呼吸器アレルギー、糖尿病などの慢性疾患の増加、医薬品ドラッグデリバリー製品の使用に関する意識の高まり、APAC地域全体のライフサイエンス産業の成長などの要因から、予測期間中に最も高いCAGRで成長すると予想されています。

本調査の目的は、近年における様々なセグメントや国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 医薬品ドラッグデリバリー市場、地域別、2019年～2029年
    • 医薬品ドラッグデリバリー市場、投与経路別、2019年～2029年
    • 医薬品ドラッグデリバリー市場、用途別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 医薬品ドラッグデリバリーの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 医薬品ドラッグデリバリーの世界市場力学

  • 医薬品ドラッグデリバリー市場の影響分析（2019-2029年）
    • 市場促進要因
      • 人口に占める慢性疾患の発生率の高さ
      • 医薬品研究開発への投資の拡大
    • 市場の課題
      • 医薬品回収・薬害の増加
    • 市場機会
      • 自己管理、在宅介護の動向が活発化
      • 技術進歩や新製品発売の増加

第4章 医薬品ドラッグデリバリーの世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 医薬品ドラッグデリバリーの世界市場：投与経路別

  • 市場スナップショット
  • 医薬品ドラッグデリバリーの世界市場：投与経路別、実績 - ポテンシャル分析
  • 医薬品ドラッグデリバリーの世界市場、投与経路別推定・予測2019-2029
  • 医薬品ドラッグデリバリー市場、サブセグメント分析
    • 経口ドラッグデリバリーシステム
    • 経鼻ドラッグデリバリーシステム
    • 眼科用ドラッグデリバリーシステム
    • 局所ドラッグデリバリーシステム
    • その他ドラッグデリバリーシステム

第7章 医薬品ドラッグデリバリーの世界市場：用途別

  • 市場スナップショット
  • 医薬品ドラッグデリバリーの世界市場：用途別、実績- ポテンシャル分析
  • 医薬品ドラッグデリバリーの世界市場推定・予測（用途別） 2019-2029
  • 医薬品ドラッグデリバリー市場、サブセグメント分析
    • がん（Cancer
    • 糖尿病
    • 循環器系疾患
    • その他

第8章 医薬品ドラッグデリバリーの世界市場：地域別分析

  • 医薬品ドラッグデリバリー市場、地域別市場スナップショット
  • 北米
    • 米国
      • 投与経路別の推定・予測、2019年～2029年
      • 用途別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の医薬品ドラッグデリバリー市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の医薬品医薬品ドラッグデリバリー市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの医薬品ドラッグデリバリー市場のスナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Bayer AG
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline Plc
    • Johnson & Johnson Private Limited
    • Merck & Co., Inc.
    • Novartis AG
    • 3M Company
    • Pfizer Inc.
    • Sanofi S.A.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Pharmaceutical Drug Delivery Market, report scope
  • TABLE 2. Global Pharmaceutical Drug Delivery Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pharmaceutical Drug Delivery Market estimates & forecasts by Route Of Administration 2019-2029 (USD Billion)
  • TABLE 4. Global Pharmaceutical Drug Delivery Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Pharmaceutical Drug Delivery Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Pharmaceutical Drug Delivery Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pharmaceutical Drug Delivery Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pharmaceutical Drug Delivery Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pharmaceutical Drug Delivery Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pharmaceutical Drug Delivery Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pharmaceutical Drug Delivery Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pharmaceutical Drug Delivery Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pharmaceutical Drug Delivery Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pharmaceutical Drug Delivery Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Pharmaceutical Drug Delivery Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Pharmaceutical Drug Delivery Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Pharmaceutical Drug Delivery Market
  • TABLE 70. List of primary sources, used in the study of global Pharmaceutical Drug Delivery Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pharmaceutical Drug Delivery Market, research methodology
  • FIG 2. Global Pharmaceutical Drug Delivery Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pharmaceutical Drug Delivery Market, key trends 2021
  • FIG 5. Global Pharmaceutical Drug Delivery Market, growth prospects 2022-2029
  • FIG 6. Global Pharmaceutical Drug Delivery Market, porters 5 force model
  • FIG 7. Global Pharmaceutical Drug Delivery Market, pest analysis
  • FIG 8. Global Pharmaceutical Drug Delivery Market, value chain analysis
  • FIG 9. Global Pharmaceutical Drug Delivery Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pharmaceutical Drug Delivery Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pharmaceutical Drug Delivery Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pharmaceutical Drug Delivery Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pharmaceutical Drug Delivery Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pharmaceutical Drug Delivery Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pharmaceutical Drug Delivery Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pharmaceutical Drug Delivery Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pharmaceutical Drug Delivery Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pharmaceutical Drug Delivery Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pharmaceutical Drug Delivery Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Pharmaceutical Drug Delivery Market is valued at approximately USD 1377.28 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.7% over the forecast period 2022-2029. Pharmaceutical drug delivery is a formulation or device used to administer a medicinal material into the body. This technique works by delivering pharmaceuticals to the body's targeted areas with the use of a medium that can control the administration of the therapy using either a chemical or a physiological trigger. The different routes by which pharmaceutical medications are administered are oral, intravenous injection, cutaneous absorption, and inhalation. The global market growth is being driven by the factors such as high incidences of chronic diseases among the population, surging demand for biosimilars and biologics, increasing government support for research in the field of drug delivery, and rising concerns & awareness about health care. The World Health Organization stated that cardiovascular diseases account for the leading cause of death with around 17.9 million cases worldwide. Similarly, according to the International Diabetes Federation, the diabetic population is likely to reach 783 million by the year 2045.

In addition, the growing investments in pharmaceutical R&D are acting as a catalyzing factor for the growth of the market across the globe. The globalization of healthcare has expanded the scope of pharmaceuticals, which represents significant growth opportunities. Pharmaceutical companies are investing in R&D to develop drugs that are tailored to the specific needs of the customers. As per Statista, in 2020, the total overall R&D spending in the pharmaceutical sector accounted for USD 207 billion and it is projected to reach around USD 265 billion by the year 2025. Thereby, the increasing investments in pharmaceutical R&D are attributed to market development. Moreover, the growing trend of self-administration and home care, as well as increasing technological advancements and new product launches are presenting various lucrative opportunities over the forecasting years. However, the increasing number of drug recalls and drug failures is challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the easy availability of pharmaceutical drug delivery systems, rising government support, rising government initiatives, along with modernize healthcare infrastructure. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing incidences of chronic diseases including cancer, respiratory allergies, and diabetes, rising awareness regarding the use of pharmaceutical drug delivery products as well as the growth of the life science industry across the APAC region.

Major market players included in this report are:

  • Bayer AG
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson Private Limited
  • Merck & Co., Inc.
  • Novartis AG
  • 3M Company
  • Pfizer Inc.
  • Sanofi S.A.

Recent Developments in the Market:

  • In June 2020, GlaxoSmithKline plc partnered with IDEAYA to enter the field of synthetic lethality, which continues to advance in oncology. The clinical trials for its programs MAT2A, Pol Theta, and Werner Helicase are anticipated to begin within the next three years.
  • In July 2021, Johnson & Johnson received FDA approval for DARZALEX (daratumumab), a subcutaneous formulation that shortens the duration of treatment for multiple myeloma patients.

Global Pharmaceutical Drug Delivery Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Route Of Administration, Application, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Route Of Administration:

  • Oral drug delivery system
  • Nasal drug delivery system
  • Ocular drug delivery systems
  • Topical drug delivery system
  • Other drug delivery system

By Application:

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pharmaceutical Drug Delivery Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pharmaceutical Drug Delivery Market, by Route Of Administration, 2019-2029 (USD Billion)
    • 1.2.3. Pharmaceutical Drug Delivery Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pharmaceutical Drug Delivery Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Drug Delivery Market Dynamics

  • 3.1. Pharmaceutical Drug Delivery Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High incidences of chronic diseases among the population
      • 3.1.1.2. Growing investments in pharmaceutical R&D
    • 3.1.2. Market Challenges
      • 3.1.2.1. Increasing number of drug recalls and drug failures
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing trend of self-administration and home care
      • 3.1.3.2. Increasing technological advancements and new product launches

Chapter 4. Global Pharmaceutical Drug Delivery Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Drug Delivery Market, by Route Of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Pharmaceutical Drug Delivery Market by Route Of Administration, Performance - Potential Analysis
  • 6.3. Global Pharmaceutical Drug Delivery Market Estimates & Forecasts by Route Of Administration 2019-2029 (USD Billion)
  • 6.4. Pharmaceutical Drug Delivery Market, Sub Segment Analysis
    • 6.4.1. Oral drug delivery system
    • 6.4.2. Nasal drug delivery system
    • 6.4.3. Ocular drug delivery systems
    • 6.4.4. Topical drug delivery system
    • 6.4.5. Other drug delivery system

Chapter 7. Global Pharmaceutical Drug Delivery Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Pharmaceutical Drug Delivery Market by Application, Performance - Potential Analysis
  • 7.3. Global Pharmaceutical Drug Delivery Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Pharmaceutical Drug Delivery Market, Sub Segment Analysis
    • 7.4.1. Cancer
    • 7.4.2. Diabetes
    • 7.4.3. Cardiovascular Diseases
    • 7.4.4. Others

Chapter 8. Global Pharmaceutical Drug Delivery Market, Regional Analysis

  • 8.1. Pharmaceutical Drug Delivery Market, Regional Market Snapshot
  • 8.2. North America Pharmaceutical Drug Delivery Market
    • 8.2.1. U.S. Pharmaceutical Drug Delivery Market
      • 8.2.1.1. Route Of Administration breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Pharmaceutical Drug Delivery Market
  • 8.3. Europe Pharmaceutical Drug Delivery Market Snapshot
    • 8.3.1. U.K. Pharmaceutical Drug Delivery Market
    • 8.3.2. Germany Pharmaceutical Drug Delivery Market
    • 8.3.3. France Pharmaceutical Drug Delivery Market
    • 8.3.4. Spain Pharmaceutical Drug Delivery Market
    • 8.3.5. Italy Pharmaceutical Drug Delivery Market
    • 8.3.6. Rest of Europe Pharmaceutical Drug Delivery Market
  • 8.4. Asia-Pacific Pharmaceutical Drug Delivery Market Snapshot
    • 8.4.1. China Pharmaceutical Drug Delivery Market
    • 8.4.2. India Pharmaceutical Drug Delivery Market
    • 8.4.3. Japan Pharmaceutical Drug Delivery Market
    • 8.4.4. Australia Pharmaceutical Drug Delivery Market
    • 8.4.5. South Korea Pharmaceutical Drug Delivery Market
    • 8.4.6. Rest of Asia Pacific Pharmaceutical Drug Delivery Market
  • 8.5. Latin America Pharmaceutical Drug Delivery Market Snapshot
    • 8.5.1. Brazil Pharmaceutical Drug Delivery Market
    • 8.5.2. Mexico Pharmaceutical Drug Delivery Market
    • 8.5.3. Rest of Latin America Pharmaceutical Drug Delivery Market
  • 8.6. Rest of The World Pharmaceutical Drug Delivery Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bayer AG
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Becton, Dickinson and Company
    • 9.2.3. F. Hoffmann-La Roche AG
    • 9.2.4. GlaxoSmithKline Plc
    • 9.2.5. Johnson & Johnson Private Limited
    • 9.2.6. Merck & Co., Inc.
    • 9.2.7. Novartis AG
    • 9.2.8. 3M Company
    • 9.2.9. Pfizer Inc.
    • 9.2.10. Sanofi S.A.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption